69.48 F
New York
October 25, 2021

PHAR08

U.S. has administered nearly 414 mln doses of COVID-19 vaccines

Reuters
A person receives a dose of the Pfizer-BioNTech vaccine for the coronavirus disease (COVID-19) as New York State Governor Kathy Hochul speaks during a news conference about the coronavirus disease (COVID-19) vaccination mandate for healthcare workers, in New York City, U.S., September 27, 2021. REUTERS/David ‘Dee’ Delgado Oct 24 (Reuters)......

U.S. CDC advisers back Moderna, J&J COVID-19 vaccine boosters, mix-and-match shots

Reuters
A general view of the U.S. Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell Oct 21 (Reuters) – A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Thursday unanimously recommended use of COVID-19 vaccine boosters for......

Merck pill seen as ‘a huge advance’, raises hope of preventing COVID-19 deaths

Reuters
An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS Co will seek U.S. approval for......

British gas pumps still dry, pig cull fears grow

Reuters
A worker guides vehicles into the forecourt as they queue to refill at a fuel station in London, Britain, September 30, 2021. REUTERS/Hannah McKay Many gas stations still closed – Reuters reporters Britain says crisis stabilising More than a quarter of gas stations dry Pig cull fears: farmers warn butcher......

Merck KGaA, GSK end partnership on former cancer drug hopeful

Reuters
FRANKFURT, Sept 30 (Reuters) – Germany’s Merck KGaA (MRCG.DE) and Britain’s GlaxoSmithKline (GSK.L) on Thursday ended their collaboration on cancer treatment bintrafusp alfa, once seen as one of Merck’s most promising experimental drugs. Merck said the move was a mutual decision, mostly due to disappointing lung cancer trial data, adding......

Merck to buy Acceleron for about $11.5 bln in rare disease drug push

Reuters
Sept 30 (Reuters) – Merck & Co (MRK.N) is buying Acceleron Pharma Inc (XLRN.O) for about $11.5 billion, broadening its portfolio beyond aging cancer drug Keytruda with potential treatments that could bring in fresh revenue. The deal gives Merck access to Acceleron’s rare disease drug candidate, sotatercept, which the company......

S&P 500, Dow gain amid inflation concerns, debt ceiling debate

Reuters
Dow top gainer, boosted by Boeing Fed Chair Powell expresses frustration over supply chain woes Indexes: Dow up 0.26%, S&P rises 0.16%, Nasdaq off 0.24% NEW YORK, Sept 29 (Reuters) – Wall Street ended firmer on Wednesday in a partial rebound from the previous day’s broad sell-off, with remarks from......

Drug distributors strike 1st opioid settlement with Native American tribe for $75 mln

Reuters
Sept 28 (Reuters) – The three largest U.S. drug distributors will pay more than $75 million to resolve claims they fueled an opioid epidemic in the Cherokee Nation’s territory in Oklahoma, marking the first settlement with a tribal government in the litigation over the U.S. addiction crisis. Cherokee Nation Principal......

COVID-19 pill developers aim to top Merck, Pfizer efforts

Reuters
Sept 28 (Reuters) – As Merck & Co (MRK.N) and Pfizer Inc (PFE.N) prepare to report clinical trial results for experimental COVID-19 antiviral pills, rivals are lining up with what they hope will prove to be more potent and convenient oral treatments of their own. Enanta Pharmaceuticals (ENTA.O), Pardes Biosciences,......

Sanofi ditches mRNA COVID-19 vaccine after rivals’ success

Reuters
To focus on more conventional COVID-19 vaccine with GSK To pursue mRNA technology in influenza, other vaccines Started testing mRNA flu shot in humans in June PARIS, Sept 28 (Reuters) – Sanofi (SASY.PA) is dropping plans for its own mRNA-based COVID-19 vaccine because of the dominance achieved by BioNTech-Pfizer and......

Pfizer submits data for COVID-19 vaccine use in younger kids

Reuters
A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic Sept 28 (Reuters) – Pfizer Inc (PFE.N) and BioNTech SE on Tuesday submitted initial trial data for their......

Pfizer begins study of oral drug for prevention of COVID-19

Reuters
Sept 27 (Reuters) – Pfizer Inc (PFE.N) said on Monday it has started a large study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus. The drugmaker and its rivals, including U.S.-based Merck & Co Inc (MRK.N) and......

Biden gets COVID-19 booster shot as additional doses roll out

Reuters
WASHINGTON, Sept 27 (Reuters) – U.S. President Joe Biden rolled up his shirt sleeve for a COVID-19 vaccine booster inoculation on Monday, hoping to provide a powerful example for Americans on the need to get the extra shot even as millions go without their first. In getting the booster, Biden......

Brazil approves COVID-19 booster shots for healthcare workers

Reuters
Brazil’s Health Minister Marcelo Queiroga attends a news conference at the Planalto Palace in Brasilia, Brazil, July 29, 2021. REUTERS/Adriano Machado BRASILIA, Sept 24 (Reuters) – Brazil has approved booster doses of COVID-19 vaccines for “health professionals,” with preference given to the Pfizer (PFE.N) shot, Health Minister Marcelo Queiroga said......

Australia hits vaccine milestone as Melbourne cases hover near record levels

Reuters
A healthcare worker walks down stairs at the Kings Park townhouse complex locked down in response to an outbreak of the coronavirus disease (COVID-19), in Melbourne, Australia, June 16, 2021. REUTERS/Sandra Sanders Australia passes 50% double-dose vaccine mark Two million doses administered in a week Seeing ‘pleasing declines’ in NSW......

Linda Evangelista files $50 mln lawsuit over disfiguring cosmetic treatment

Reuters
LOS ANGELES, Sept 23 (Reuters) – Former supermodel Linda Evangelista has filed a $50 million lawsuit over cosmetic procedures that she says left her “brutally disfigured” and turned her into a recluse. The Canadian model, one of the biggest figures on runways and magazine covers in the 1990s, said in......

U.S. CDC director breaks with panel, backs COVID-19 boosters for high-risk workers

Reuters
Sept 24 (Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Friday backed a booster shot of the Pfizer (PFE.N) and BioNTech COVID-19 vaccine for Americans aged 65 and older, some adults with underlying medical conditions and some adults in high-risk working and institutional settings. The move......

U.S. FDA clears Pfizer COVID-19 booster for older and at-risk Americans

Reuters
WASHINGTON, Sept 22 (Reuters) – The U.S. Food and Drug Administration on Wednesday authorized a booster dose of the Pfizer Inc (PFE.N) and BioNTech COVID-19 vaccine for those 65 and older, all people at high risk of severe disease, and others who are regularly exposed to the virus. The decision......

Under pressure, U.S. donates half billion more COVID-19 vaccine doses to world

Reuters
WASHINGTON, Sept 22 (Reuters) – The United States on Wednesday promised to buy 500 million more COVID-19 vaccine doses to donate to other countries as it comes under increasing pressure to share its supply with the rest of the world. President Joe Biden made the announcement during a virtual summit......

Severe COVID-19 may trigger autoimmune conditions; New variants cause more virus in the air

Reuters
The word “COVID-19” is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo Sept 22 (Reuters) – The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that......

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More